Literature DB >> 10496490

Aortic valve replacement for aortic regurgitation in a patient with primary antiphospholipid syndrome.

K Matsuyama1, Y Ueda, H Ogino, T Sugita, K Matsubayashi, T Nomoto, S Yoshimura, T Yoshioka.   

Abstract

A 42-year-old woman with the diagnosis of aortic regurgitation was admitted to hospital for surgical treatment. Ten years ago, primary antiphospholipid syndrome had been diagnosed, and she had a history of recurrent spontaneous abortions and deep vein thrombosis. She was suffering from moderate exertional dyspnea and chest pain. Catheter investigation revealed progressive dilatation of the left ventricle and a deterioration of the ejection fraction. The aortic valve was excised and replaced with a mechanical valve. A specimen of the aortic valve showed localized thickening and shrinkage of the midportion and base of each cusp, with vegetation on the surface. These localized, specific findings suggest that another mechanism may be involved in the cardiac valve pathology in patients with primary antiphospholipid syndrome. No hemostatic or thromboembolic problems were encountered after the surgery, and her postoperative course was uneventful.

Entities:  

Mesh:

Year:  1999        PMID: 10496490     DOI: 10.1253/jcj.63.725

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  2 in total

1.  Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome.

Authors:  Nozomu Sasahashi; Hisao Harada; Yoshiaki Saji; Akira Marui; Takeshi Nishina; Masashi Komeda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-07

2.  Does antiphospholipid antibody syndrome affect bioprosthetic heart valve? Midterm echocardiographic report.

Authors:  Shunei Saito; Hiroshi Ikeguchi; Harumitsu Yamamoto; Akira Koike; Kazuo Yamaguchi; Eiji Takeuchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.